$IFRX
InflaRx N.V. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$1.45
▲+9.85%+$0.130
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateInflaRx N.V. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is IFRX up today? It is at $1.45 (+9.85%), and our scanner flagged it 51 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment IFRX spikes, and full due diligence on IFRX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $IFRX 51 times in the last 30 days. Create a free account to track $IFRX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on IFRX from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
Likely catalystForeign issuer report (6-K), from an SEC filing. Read it →Latest filingSC 13GPassive 5%+ stake disclosedAug 17, 2026 · 63 days agoAcross every filing on file, supply equal to 156.7% of the tradeable float is in play - 156.7% more can still be issued.
Shelf sizes are dollars, so shares are estimated at today's price.
One filing exceeds the whole float, which usually means our share count is stale. Check the filing directly.
At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing)
65,000,000 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time · About $65.0M in size
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on IFRX from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
IFRX last traded at $1.45, up 9.85% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
InflaRx N.V. Common Stock (IFRX) is next expected to report earnings on Monday, November 9, 2026, about 21 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The IFRX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged IFRX 51 times in the last 30 days.
IFRX (InflaRx N.V. Common Stock) trades on XNAS, with a market cap of about $214M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge IFRX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$IFRX discussion
Sign in to ask a question or join the discussion.